Inhalation Sciences Sweden AB Share Price OTC Markets
Stocks
INHSF
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 24/08 | Inhalation Sciences Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 24/08 | Inhalation Sciences narrows its loss | FW |
| Market Cap | 71.68L 8L 6L 6L 6L 10.48L 7.21Cr 10.58L 27.9L 3.64Cr 28.42L 27.8L 12Cr | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 43.37L 5L 4L 4L 3L 6L 4.37Cr 6L 16.88L 2.2Cr 17.19L 16.82L 7.29Cr | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
81.56% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 16/09/2019 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2005 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 01/01/2005 |
Jan Hellqvist
BRD | Director/Board Member | - | 01/09/2022 |
Ulf Ericsson
BRD | Director/Board Member | - | 01/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8L | |
| -0.09% | +6.64% | +28.00% | +15.98% | 23TCr | |
| +0.40% | +8.21% | +3.97% | -15.48% | 15TCr | |
| -0.46% | -4.94% | -20.62% | +24.97% | 13TCr | |
| +1.73% | -1.21% | -52.56% | -1.77% | 7.23TCr | |
| -0.82% | -1.78% | -16.87% | -14.16% | 5.16TCr | |
| +0.41% | -0.12% | +12.38% | +19.30% | 5.24TCr | |
| +0.87% | +4.26% | +29.90% | +29.32% | 4.37TCr | |
| +0.90% | +3.29% | +38.63% | +51.60% | 4.07TCr | |
| +0.79% | +19.49% | +125.76% | +42.33% | 3.4TCr | |
| Average | +0.27% | +3.90% | +16.51% | +16.90% | 9TCr | |
| Weighted average by Cap. | +0.21% | +3.71% | +9.29% | +11.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.1Cr 11.66L 10L 9L 9L 16.14L 11Cr 16.3L 43.01L 5.61Cr 43.8L 42.84L 19Cr | 30.41L 3L 3L 3L 2L 4L 3.06Cr 4L 11.84L 1.54Cr 12.06L 11.79L 5.11Cr |
| Net income | -51.47L -5L -5L -4L -4L -8L -5.18Cr -8L -20.04L -2.61Cr -20.41L -19.96L -8.66Cr | -1.02Cr -10.73L -9L -9L -8L -14.85L -10Cr -14.99L -39.55L -5.16Cr -40.28L -39.4L -17Cr |
| Net Debt | -40.03L -4L -4L -3L -3L -6L -4.03Cr -6L -15.58L -2.03Cr -15.87L -15.52L -6.73Cr | -28.31L -3L -3L -2L -2L -4L -2.85Cr -4L -11.02L -1.44Cr -11.22L -10.98L -4.76Cr |
Employees
5
Net sales - Rate of surprise
- Stock Market
- Stocks
- ISAB Stock
- INHSF Stock
Select your edition
All financial news and data tailored to specific country editions
